Clinical Trial

Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

Study acronym: SARC-ENDO
Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, observational, single-center, study evaluating the prevalence of sarcopenia / sarcopenic obesity in individuals with metabolic and / or endocrine diseases, as well as the potential role of myokines as biomarkers or drivers of sarcopenia / sarcopenic obesity in this population. .
Trial Details
NCT Number NCT07703683
Lead Sponsor Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions Diabetes, Obesity & Overweight, Cushing Syndrome, Metabolic Diseases, Endocrine Diseases, Sarcopenia, Sarcopenic Obesity
Enrollment 100 participants
Start Date 2026-02-19
Primary Completion 2056-12-31 (estimated)
Study Completion 2056-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-14